Mild Cognitive Impairment (MCI)/Mild Dementia Diagnostics/Therapies w/ Doug Elwood, MD, MBA, and Mark Hanson, PhD 3/4/25

Conversation w/ Doug Elwood, MD, MBA, Chief Medical Officer, and Mark Hanson, PhD, Adviser, Sunday Health, about the interrelationship between biomarkers and artificial intelligence, and other promising diagnostic tools and therapies, which enhance early detection and personalized treatment strategies for MCI and mild dementia.